CoChat

The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

Open access
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, Lisa, Kaptoge, Stephen, Østergaard, Helena Bleken, Read, Stephanie H, Carinci, Fabrizio, Franch-Nadal, Josep, Petitjean, Carmen, Taylor, Owen, Hageman, Steven H J, Xu, Zhe, Shi, Fanchao, Spackman, Sarah, Gualdi, Stefano, Holman, Naomi, Da Providencia E Costa, Rui Bebiano, Bonnet, Fabrice, Brenner, Hermann, Gillum, Richard F, Kiechl, Stefan, Lawlor, Deborah A, Potier, Louis, Schöttker, Ben, Sofat, Reecha, Völzke, Henry, Willeit, Johann, Baltane, Zane, Fava, Stephen, Janos, Sandor, Lavens, Astrid, Pildava, Santa, Poljicanin, Tamara, Pristas, Ivan, Rossing, Peter, Sascha, Reiff, Scheidt-Nave, Christa, Stotl, Iztok, Tibor, Gail, Urbančič-Rovan, Vilma, Vanherwegen, An-Sofie, Vistisen, Dorte, Du, Yong, Walker, Matthew R, Willeit, Peter, Ference, Brian, De Bacquer, Dirk, Halle, Martin, Huculeci, Radu, McEvoy, John William, Timmis, Adam, Vardas, Panagiotis, Dorresteijn, Jannick A N, Graham, Ian, Wood, Angela, Eliasson, Björn, Herrington, William, Danesh, John, Mauricio, Dídac, Benedetti, Massimo Massi, Sattar, Naveed, Visseren, Frank L J, Wild, Sarah, Di Angelantonio, Emanuele, Balkau, Beverley, Bonnet, Fabrice, Fumeron, Frederic, Stocker, Hannah, Holleczek, Bernd, Schipf, Sabine, Schmidt, Carsten Oliver, Dörr, Marcus, Tilg, Herbert, Leitner, Christoph, Notdurfter, Marlene, Taylor, Julie, Dale, Caroline, Prieto-Merino, David, Gillum, Richard F, Lavens, Astrid, Vanherwegen, An-Sofie, Poljicanin, Tamara, Pristas, Ivan, Buble, Tamara, Ivanko, Pero, Rossing, Peter, Carstensen, Bendix, Heidemann, Christin, Du, Yong, Scheidt-Nave, Christa, Gall, Tibor, Sandor, Janos, Baltane, Zane, Pildava, Santa, Lepiksone, Jana, Magri, Caroline J, Azzopardi, Joseph, Stotl, Iztok, Real, Jordi, Vlacho, Bogdan, Mata-Cases, Manel · 2023 · European Heart Journal

Abstract

Aims: To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease (CVD) in individuals with type 2 diabetes in Europe. Methods and results: SCORE2-Diabetes was developed by extending SCORE2 algorithms using individual-participant data from four large-scale datasets comprising 229 460 participants (43 706 CVD events) with type 2 diabetes and without previous CVD. Sex-specific competing risk-adjusted models were used including conventional risk factors (i.e. age, smoking, systolic blood pressure, total, and HDL-cholesterol), as well as diabetes-related variables (i.e. age at diabetes diagnosis, glycated haemoglobin [HbA1c] and creatinine-based estimated glomerular filtration rate [eGFR]). Models were recalibrated to CVD incidence in four European risk regions. External validation included 217 036 further individuals (38 602 CVD events), and showed good discrimination, and improvement over SCORE2 (C-index change from 0.009 to 0.031). Regional calibration was satisfactory. SCORE2-Diabetes risk predictions varied several-fold, depending on individuals’ levels of diabetes-related factors. For example, in the moderate-risk region, the estimated 10-year CVD risk was 11% for a 60-year-old man, non-smoker, with type 2 diabetes, average conventional risk factors, HbA1c of 50 mmol/mol, eGFR of 90 mL/min/1.73 m2, and age at diabetes diagnosis of 60 years. By contrast, the estimated risk was 17% in a similar man, with HbA1c of 70 mmol/mol, eGFR of 60 mL/min/1.73 m2, and age at diabetes diagnosis of 50 years. For a woman with the same characteristics, the risk was 8% and 13%, respectively. Conclusion: SCORE2-Diabetes, a new algorithm developed, calibrated, and validated to predict 10-year risk of CVD in individuals with type 2 diabetes, enhances identification of individuals at higher risk of developing CVD across Europe.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehad260

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Structured Graphical Abstract SCORE2-Diabetes 10-year CVD risk models: development process, key features and illustrative example. CVD: cardiovascular disease; SBP: systolic blood pressure; HDL-C: high-density lipoprotein cholesterol; HbA1c (mmol/mol): glycated haemoglobin, in International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units; eGFR: estimated Glomerular Filtration Rate (mL/min/1.73m2).
Structured Graphical Abstract SCORE2-Diabetes 10-year CVD risk models: development process, key features and illustrative example. CVD: cardiovascular disease; SBP: systolic blood pressure; HDL-C: high-density lipoprotein cholesterol; HbA1c (mmol/mol): glycated haemoglobin, in International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units; eGFR: estimated Glomerular Filtration Rate (mL/min/1.73m2).CC BY-NC · PubMed Central
Figure 1 Study design for the SCORE2-Diabetes project. ERFC: Emerging Risk Factors Collaboration, CPRD: Clinical Practice Research Datalink, SCID: Scottish Care Information—Diabetes, SNDR: Swedish National Diabetes Register, SIDIAP: Sistema d'Informació per al Desenvolupament de la Investigació en Atenció Primària, EUBIROD: EUropean Best Information through Regional Outcome in Diabetes, eGFR: estimated Glomerular Filtration Rate, HbA1c: glycated haemoglobin.
Figure 1 Study design for the SCORE2-Diabetes project. ERFC: Emerging Risk Factors Collaboration, CPRD: Clinical Practice Research Datalink, SCID: Scottish Care Information—Diabetes, SNDR: Swedish National Diabetes Register, SIDIAP: Sistema d'Informació per al Desenvolupament de la Investigació en Atenció Primària, EUBIROD: EUropean Best Information through Regional Outcome in Diabetes, eGFR: estimated Glomerular Filtration Rate, HbA1c: glycated haemoglobin.CC BY-NC · PubMed Central
Figure 2 Internal and External validation of the SCORE2-Diabetes models: ability to discriminate CVD risk. CPRD: Clinical Practice Research Datalink; ERFC: Emerging Risk Factors Collaboration; UKB: UK Biobank; SCID: Scottish Care Information—Diabetes; SIDIAP: Sistema d'Informació per al Desenvolupament de la Investigació en Atenció Primària; SNDR: Swedish National Diabetes Register.
Figure 2 Internal and External validation of the SCORE2-Diabetes models: ability to discriminate CVD risk. CPRD: Clinical Practice Research Datalink; ERFC: Emerging Risk Factors Collaboration; UKB: UK Biobank; SCID: Scottish Care Information—Diabetes; SIDIAP: Sistema d'Informació per al Desenvolupament de la Investigació en Atenció Primària; SNDR: Swedish National Diabetes Register.CC BY-NC · PubMed Central
Figure 3 Estimates are for non-smokers with systolic blood pressure of 140 mm Hg, total cholesterol of 5.5 mmol/L and HDL-cholesterol of 1.3 mmol/L. eGFR: estimated Glomerular Filtration Rate (mL/min/1.73 m2) calculated using the CKD-EPI 2009 equations; HbA1c (mmol/mol): glycated haemoglobin, in International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units.
Figure 3 Estimates are for non-smokers with systolic blood pressure of 140 mm Hg, total cholesterol of 5.5 mmol/L and HDL-cholesterol of 1.3 mmol/L. eGFR: estimated Glomerular Filtration Rate (mL/min/1.73 m2) calculated using the CKD-EPI 2009 equations; HbA1c (mmol/mol): glycated haemoglobin, in International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units.CC BY-NC · PubMed Central
Figure 4 The proportion of individuals expected in each risk category was estimated to reflect the age-group and sex-specific risk factor values in each risk region (see Supplementary data online, Supplementary methods).
Figure 4 The proportion of individuals expected in each risk category was estimated to reflect the age-group and sex-specific risk factor values in each risk region (see Supplementary data online, Supplementary methods).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. Bolibar, 2012, SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research, Med Clin (Barc), 138, 617

Cited by

See all 376

Metadata

Authors
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., Xu, Z., Shi, F., Spackman, S., Gualdi, S., Holman, N., Da Providencia E Costa, R. B., Bonnet, F., Brenner, H., Gillum, R. F., Kiechl, S., Lawlor, D. A., Potier, L., Schöttker, B., Sofat, R., Völzke, H., Willeit, J., Baltane, Z., Fava, S., Janos, S., Lavens, A., Pildava, S., Poljicanin, T., Pristas, I., Rossing, P., Sascha, R., Scheidt-Nave, C., Stotl, I., Tibor, G., Urbančič-Rovan, V., Vanherwegen, A.-S., Vistisen, D., Du, Y., Walker, M. R., Willeit, P., Ference, B., De Bacquer, D., Halle, M., Huculeci, R., McEvoy, J. W., Timmis, A., Vardas, P., Dorresteijn, J. A. N., Graham, I., Wood, A., Eliasson, B., Herrington, W., Danesh, J., Mauricio, D., Benedetti, M. M., Sattar, N., Visseren, F. L. J., Wild, S., Di Angelantonio, E., Balkau, B., Bonnet, F., Fumeron, F., Stocker, H., Holleczek, B., Schipf, S., Schmidt, C. O., Dörr, M., Tilg, H., Leitner, C., Notdurfter, M., Taylor, J., Dale, C., Prieto-Merino, D., Gillum, R. F., Lavens, A., Vanherwegen, A.-S., Poljicanin, T., Pristas, I., Buble, T., Ivanko, P., Rossing, P., Carstensen, B., Heidemann, C., Du, Y., Scheidt-Nave, C., Gall, T., Sandor, J., Baltane, Z., Pildava, S., Lepiksone, J., Magri, C. J., Azzopardi, J., Stotl, I., Real, J., Vlacho, B., & Mata-Cases, M.
Venue
European Heart Journal
Published
2023-05-29
Volume
44
Issue
28
Pages
2544-2556
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4378746292
Cited by
329
References
38
Citations by year
2026: 102 · 2025: 120 · 2024: 89 · 2023: 18
FWCI
67.70
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by-nc)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc)
  • UCL Discovery (University College London) (submittedVersion, cc-by-nc)
  • Lirias (KU Leuven) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by-nc)
Funders
  • British Heart Foundation (RG/13/13/30194, RG/18/13/33946)
  • BHF Centre of Research Excellence (RE/18/1/34212)
  • UK Medical Research Council (MR/L003120/1)
  • National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre (BRC-1215–20014)
  • NIHR
  • British United Provident Association (BUPA) Foundation
  • GlaxoSmithKline
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
cardiovascular risk prediction, type 2 diabetes, 10-year cardiovascular risk, SCORE2, HbA1c, estimated glomerular filtration rate, age at diabetes diagnosis, risk recalibration, external validation
MeSH terms
Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Europe, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. https://app.cochat.ai/papers/10.1093/eurheartj/ehad260
The paper
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., Xu, Z., Shi, F., Spackman, S., Gualdi, S., Holman, N., Da Providencia E Costa, R. B., Bonnet, F., Brenner, H., Gillum, R. F., . . . Mata-Cases, M. (2023). SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. European Heart Journal. https://doi.org/10.1093/eurheartj/ehad260

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.